You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells

Citation Tools

Article menu

Download PDFPDF

XML
Immune cell therapies and immune cell engineering
Original research
Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Iida Y, Yoshikawa R, Murata A, et al
Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells
Journal for ImmunoTherapy of Cancer 2020;8:e000582. doi: 10.1136/jitc-2020-000582